BIOLIFE SOLUTIONS INCBLFSEarnings & Financial Report
Biolife Solutions Inc. develops, manufactures and distributes specialized biopreservation products and cold chain management solutions for the cell and gene therapy, biopharmaceutical and regenerative medicine industries. It offers cryopreservation media, automated thawing systems, and temperature monitoring tools, serving biotech firms, research institutions and clinical labs globally.
BLFS Q4 FY2025 Key Financial Metrics
Revenue
$18.8M
Gross Profit
N/A
Operating Profit
$1.3M
Net Profit
$11.1M
Gross Margin
N/A
Operating Margin
7.2%
Net Margin
58.9%
YoY Growth
24.3%
EPS
$0.23
BIOLIFE SOLUTIONS INC Q4 FY2025 Financial Summary
BIOLIFE SOLUTIONS INC reported revenue of $18.8M (up 24.3% YoY) for Q4 FY2025, with a net profit of $11.1M (down 11.1% YoY) (58.9% margin).
Key Financial Metrics
| Total Revenue | $18.8M |
|---|---|
| Net Profit | $11.1M |
| Gross Margin | N/A |
| Operating Margin | 7.2% |
| Report Period | Q4 FY2025 |
BIOLIFE SOLUTIONS INC Annual Revenue by Year
BIOLIFE SOLUTIONS INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $96.2M).
BIOLIFE SOLUTIONS INC Quarterly Revenue & Net Profit History
BIOLIFE SOLUTIONS INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $18.8M | +24.3% | $11.1M | 58.9% |
| Q3 FY2025 | $28.1M | +31.2% | $621.0K | 2.2% |
| Q2 FY2025 | $25.4M | +28.9% | $-15.8M | -62.3% |
| Q1 FY2025 | $23.9M | +29.9% | $-448.0K | -1.9% |
| Q4 FY2024 | $15.1M | +167.2% | $12.5M | 82.5% |
| Q3 FY2024 | $21.4M | -9.3% | $-1.7M | -8.0% |
| Q2 FY2024 | $19.7M | -32.6% | $-20.7M | -105.1% |
| Q1 FY2024 | $18.4M | -51.1% | $-10.2M | -55.4% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.4M | $19.7M | $21.4M | $15.1M | $23.9M | $25.4M | $28.1M | $18.8M |
| YoY Growth | -51.1% | -32.6% | -9.3% | 167.2% | 29.9% | 28.9% | 31.2% | 24.3% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $401.6M | $375.0M | $381.7M | $399.5M | $395.1M | $387.2M | $392.1M | $405.9M |
| Liabilities | $68.2M | $53.5M | $56.2M | $50.6M | $42.5M | $40.1M | $38.3M | $34.0M |
| Equity | $333.4M | $321.4M | $325.5M | $348.9M | $352.6M | $347.2M | $353.7M | $371.9M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-4.5M | $6.5M | $4.8M | $1.6M | $1.7M | $7.4M | $6.1M | $4.9M |